THE INDIAN PHARMACIST Official Circular Pharmacy LogoTHE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
Pharmacy Practice, Drug Safety & Regulatory Science ARTICLE ID: KH-17 ⏱️ 10 min read 📅 Updated: 2026-11-10

Emergency Clinical Toxicology: Toxidromes, GI Decontamination & Specific Antidote Protocols

🎯 Key Takeaways Summary

  • Remember the 'PHAILS' mnemonic for substances NOT adsorbed by Activated Charcoal (Pesticides/Petroleum hydrocarbons, Acids/Alkalis, Iron, Lithium, Solvents/Alcohols).
  • N-Acetylcysteine (NAC) provides nearly 100% protection against paracetamol-induced hepatic necrosis when initiated within 8 hours of acute overdose.
  • See also Figure 8.12 for anticoagulant reversal antidotes.

1. Foundational Clinical & Scientific Overview

Clinical management of acute poisoning prioritises immediate Airway, Breathing, and Circulation (ABC) stabilisation, rapid recognition of autonomic/neurological Toxidromes (Cholinergic, Anticholinergic, Opioid, Sympathomimetic, Serotonergic), targeted gastrointestinal decontamination (Single-Dose Activated Charcoal 1 g/kg within 1 hour for adsorbable toxins), and timely administration of specific antidotes.

2. Core Mechanisms, Classification & Practical Framework

Activated Charcoal possesses an immense microporous surface area (1,000–1,500 m²/g) that adsorbs non-polar organic drugs in the gut lumen, but it does NOT bind 'PHAILS' toxins: Pesticides (corrosive/hydrocarbon), Hydrocarbons (aspiration risk!), Acids/Alkalis, Iron, Lithium, or Solvents/Alcohols (Methanol, Ethylene Glycol, Ethanol) and Heavy Metals (Lead, Arsenic, Cyanide).

Structured Classification & Practical Examples

  • Paracetamol (Acetaminophen) Overdose: CYP2E1 forms hepatotoxic NAPQI once glutathione is depleted -> Antidote: N-Acetylcysteine (NAC, replenish hepatic glutathione; guided by Rumack-Matthew nomogram at 4 hours post-ingestion).
  • Organophosphate / Carbamate Insecticide Poisoning ('DUMBBELS' cholinergic crisis): Antidote: Atropine Sulfate IV (blocks muscarinic bronchorrhoea/bradycardia; titrate to clear lungs!) + Pralidoxime (2-PAM, reactivates phosphorylated AChE before 'ageing' occurs in OP poisoning).
  • Opioid Overdose (Morphine, Fentanyl, Heroin — pinpoint pupils & respiratory depression): Antidote: Naloxone Hydrochloride IV/IM/IN (competitive mu-opioid antagonist; short half-life 30–90 min requires repeat dosing/infusion).
  • Benzodiazepine Overdose: Antidote: Flumazenil (avoid in chronic benzodiazepine dependence or tricyclic antidepressant co-ingestion as it precipitates refractory seizures).
  • Iron Overdose -> Deferoxamine | Copper/Wilson's -> D-Penicillamine | Lead/Mercury/Arsenic -> Dimercaprol (BAL), Succimer (DMSA), Calcium Disodium EDTA.
  • Methanol / Ethylene Glycol Poisoning -> Fomepizole (or Ethanol) to inhibit Alcohol Dehydrogenase + Folinic acid/Pyridoxine + Haemodialysis.

3. Advanced Clinical Pharmacy, Dosing & Indian Regulatory Application

Beta-Blocker, Calcium Channel Blocker & Anticoagulant Reversal Protocols: Severe Beta-Blocker overdose causing refractory bradycardia and hypotension is treated with high-dose IV Glucagon (activates myocardial Gs-adenylyl cyclase bypassing beta-1 receptors, increasing cAMP and contractility) alongside High-Dose Insulin Euglycaemic Therapy (HIET) and calcium salts (for CCB toxicity). For anticoagulant emergencies: Unfractionated Heparin is reversed by Protamine Sulfate (1 mg neutralises ~100 units UFH); Warfarin life-threatening bleeding is reversed by 4-Factor Prothrombin Complex Concentrate (PCC) + IV Vitamin K1; Dabigatran is reversed by Idarucizumab; and Apixaban/Rivaroxaban are reversed by Andexanet Alfa.

4. Common Misunderstandings & Pharmacist Safety Safeguards

⚠️ Clinical Pitfall & Safety Note: Common Misunderstanding: Using pupil size (mydriasis) as the endpoint for Atropine titration in Organophosphate poisoning. The true clinical endpoint of Atropine therapy (atropinisation) is drying of tracheobronchial secretions (clear chest auscultation without wheeze/crackles), heart rate > 80 bpm, and systolic BP > 80 mmHg.

5. Explanatory Visual Pharmacology Diagram (svg-v339-04-hepatic-cyp450-phase1-phase2)

HEPATOCYTE BIOTRANSFORMATION: PHASE I (CYP450) & PHASE II CONJUGATION Note: Extrahepatic metabolism occurs in GI enterocytes (CYP3A4), plasma pseudocholinesterase (Succinylcholine), & lungs PHASE I: FUNCTIONALISATION • Smooth ER Microsomal CYP450 Heme Enzymes • Oxidation, Hydroxylation, Dealkylation • Key Isoforms: - CYP3A4: Statins, CCBs, Macrolides - CYP2C9: S-Warfarin, Phenytoin, Glimepiride - CYP2C19: Clopidogrel (Prodrug), PPIs - CYP2D6: Codeine, Metoprolol, Risperiodone Unmasks -OH, -COOH, -NH2, -SH groups PHASE II: CONJUGATION (SYNTHETIC) • Cytosolic & ER Transferase Enzymes • Adds polar endogenous cofactor: - Glucuronidation (UGT): Morphine, Paracetamol - Sulfation (SULT): Paracetamol, Minoxidil - Acetylation (NAT2): Isoniazid, Hydralazine - Glutathione (GST): Detoxifies NAPQI Highly polar conjugate → Urine / Bile excretion PRODRUG ACTIVATION & METABOLITES Inactive Prodrug → Active Drug: • Enalapril / Ramipril → Enalaprilat / Ramiprilat • Clopidogrel (CYP2C19) → Active Thiol • Levodopa (AADC) → Dopamine Toxic Reactive Metabolite: • Paracetamol (CYP2E1) → NAPQI (Antidote: NAC) • Cyclophosphamide → Acrolein (Antidote: Mesna) CYP450 ENZYME INHIBITION (Rapid Onset: Hours) • Inhibitors: Clarithromycin, Itraconazole, Ritonavir, Ciprofloxacin, Valproate • Effect: ↓ Clearance of active substrate → ↑ Plasma levels & Toxicity Exception: Inhibiting CYP2C19 (Omeprazole) ↓ Clopidogrel activation CYP450 ENZYME INDUCTION (Transcriptional: 7–14 Days) • Inducers: Rifampicin, Phenytoin, Carbamazepine, Phenobarbital • Effect: ↑ CYP synthesis → ↑ Substrate metabolism → Therapeutic Failure NACO Rule: Rifampicin requires doubling Dolutegravir to 50 mg BD
8.4 Hepatic Drug Metabolism: Hepatocyte CYP450 Phase I, Phase II Conjugation & Prodrug Activation: Figure 8.4: Hepatocyte Phase I functionalisation (Cytochrome P450 microsomal mixed-function oxidase system) and Phase II conjugation reactions, illustrating active metabolite formation, prodrug bioactivation, and clinical CYP inhibition/induction. Note: Extrahepatic metabolism also occurs in intestinal mucosa, plasma esterases, lungs, and kidneys.

6. Authoritative References & Editorial Traceability

Primary Reference Sources: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) by Tejas Nartam; ICMR Standard Treatment Workflows; NFI & NLEM 2022.

Official Portals: CDSCO • Indian Pharmacopoeia Commission (IPC / NFI) • ICMR • FSSAI • NCBI Bookshelf

Educational Disclaimer: Published for pharmacy education, academic learning, and professional clinical reference. Never self-medicate or alter prescribed treatment without consulting a qualified medical practitioner.

← Previous: Pharmacovigilance Programme of India (PvPI... All 40 Articles Next: Renal & Hepatic Dose Individualisation: Co... →